Anti-sense oligonucleotide against clusterin sensitizes lung carcinoma H460 cells to irradiation

He-cheng LI,Jia-qing XIANG,Ya-wei ZHANG
DOI: https://doi.org/10.3781/j.issn.1000-7431.2007.01.006
2007-01-01
Tumor
Abstract:Objective:To study whether the inhibition of clusterin sensitizes lung cancer H460 cells to irradiation. Methods:The H460 cells were transfected with antisense oligonucleotide(oligo) against clusterin mediated by lipofectin. Lung cancer H460 cells were radiated by 137Cs irradiator. The percentage of apoptotic cells was determined by flow-cytometry analysis of 7-AAD stained cells. Cell proliferation was measured by MTT and clonogenic assay. Results:Antisense oligonucleotides of clusterin caused specific attenuation of secreted clusterin, but exerted no effect on nuclear clusterin. Compared with control group, transfection with antisense oligonucleotide against clusterin or irradiation alone increased the apoptotic ratio from 5% to 10%, but irradiation combined with antisense oligonucleotide therapy significantly increased the apoptotic population to almost 25% (P<0.01). MTT and clonogenic assay showed that irradiation combined with antisense oligonucleotide therapy significantly reduced the proliferation of H460 cells in vitro compared with control group (P<0.01).Conclusion:Antisense oligonucleotide against clusterin sensitizes lung cancer H460 cells to radiotherapy in vitro.
What problem does this paper attempt to address?